-
-
-
-
-
-
-
Spero Therapeutics (SPRO) Announces Positive Topline Results from Phase 1 Bronchoalveolar Lavage Clinical Trial of SPR206
-
-
-
-
-
-
-
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
-
-
-
-
-
-
-
Spero Announces Appointment of Cynthia Smith to its Board of Directors
-
-
-
-
-
-
-
Kaplan Completes SmartPros Acquisition Expanding Its Continuing Education Offering in Accountancy and Financial Services
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

